Abstract
Objective
The American Academy of Clinical Toxicology, European Association of Poisons Centres, and Clinical Toxicologists recommend administration of activated charcoal (AC) within one-hour of an acute toxic ingestion [1]. Our poison control center periodically and upon request faxes an abbreviated protocol to hospital emergency departments, reminding physicians of these current AC recommendations. This study was conducted to describe how often patients present within the one-hour time frame and how often the guidelines in the above position statement are being followed.
Methods
Following a brief training of systematic chart review, reviewers blinded to the purpose of the study completed a standardized data collection sheet. Three years after publication of these consensus statements, a period of 3 consecutive years of poison center patient encounters were reviewed. Recorded data included age, outcomes, and time to administration of charcoal.
Results
Approximately 150,000 reported toxic exposures were reviewed, of which 16,914 patients of acute ingestions presented to a health care facility. The mean age of the group that presented was 25 years [range 1 month-87 years]. A total of 2,700 (16%) patients that presented were within 60 minutes of an acute overdose and all were administered AC in accordance with the recommended guidelines. Interestingly, pre-hospital personnel administered AC within 60 minutes to 762 (28% of 2,700) patients. Correspondingly, 14,214 (84%) patients presented more than 60 minutes after an acute overdose. Of this latter group AC was withheld in 341 (2.4% of 14,214) patients, and 13,873 (97.6% of 14,214) patients received charcoal despite having arrived more than 60 minutes after ingestion. The mean time to the first administration of AC in this latter group was 225 minutes [range of 61–2160 minutes] following ingestion.
Conclusions
Only a small percentage of patients treated for an acute overdose (16%) present within 60 minutes and are given charcoal according to the current guidelines. A large subset of these patients (28%) is given AC in a pre-hospital setting. Few patients presenting to a health care provider after an acute toxic ingestion are treated in accordance with the current recommendations for activated charcoal.
Keywords: charcoal, activated charcoal
Full Text
The Full Text of this article is available as a PDF (91.0 KB).
Footnotes
There was no outside funding of any kind for this study.
References
- 1.Chyka PA, Seger D. Position stataement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1997;35(7):721–741. doi: 10.3109/15563659709162569. [DOI] [PubMed] [Google Scholar]
- 2.Seger D. Single-dose activated charcoal-backup and reassess. J Toxicol Clin Toxicol. 2004;42(1):101–110. doi: 10.1081/CLT-120028754. [DOI] [PubMed] [Google Scholar]
- 3.Green R, Grierson R, Sitar DS, Tenenbein M. How long after drug ingestion is activated charcoal still effective? J Toxicol Clin Toxicol. 2001;39(6):601–605. doi: 10.1081/CLT-100108492. [DOI] [PubMed] [Google Scholar]
- 4.Dawling S, Crome P, Braithwaite R. Effect of delayed administration of activated charcoal on nortirptyline absorption. Eur J Clin pharmacol. 1978;14(6):445–447. doi: 10.1007/BF00716388. [DOI] [PubMed] [Google Scholar]
- 5.Laine K, Kivisto KT, Pelttari S, Neuvonen PJ. The effect of activated charcoal on the absorption of fluoextine, with special reference to delayed charcoal administration. Pharmacol Toxicol. 1996;79(5):270–273. doi: 10.1111/j.1600-0773.1996.tb00272.x. [DOI] [PubMed] [Google Scholar]
- 6.Laine K, Kivisto KT, Ojala-Karlsson P, Neuvonen PJ. Effect of activated charcoal on the pharmacokinetics of pholcodine, with special reference to delayed charcoal ingestion. There Drug Monit. 1997;19(1):46–50. doi: 10.1097/00007691-199702000-00008. [DOI] [PubMed] [Google Scholar]
- 7.[No authors]Position paper: Ipecac syrup.J Toxicol Clin Toxicol. 2004;42(2):133–43. [DOI] [PubMed]
- 8.Isbister GK, Dawson AH, Whyte IM. Feasibility of prehospital treatment with activated charcoal: Who could we treat, who should we treat? Emerg Med J. 2003;20(4):375–8. doi: 10.1136/emj.20.4.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Thakore S, Murphy N. The potential role of prehospital administration of activated charcoal. Emerg Med J. 2002;19(1):63–5. doi: 10.1136/emj.19.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Bond GR. The role of activated charcoal and gastric emptying in gastrointestinal decontamination: a state-of-the-art review. Ann Emerg Med. 2002;39(3):273–86. doi: 10.1067/mem.2002.122058. [DOI] [PubMed] [Google Scholar]
- 11.Cooper GM, Le Couteur DG, Richardson D, Buckley NA. A randomized clinical trial of activated charcoal for the routine management of oral drug overdose. QJM. 2005;98(9):655–60. doi: 10.1093/qjmed/hci102. [DOI] [PubMed] [Google Scholar]